Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers

被引：0
|
作者：
Lee, Jaeyop [1 ]
Ku, Geoffrey [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Gastrointestinal Oncol Serv, New York, NY 10065 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2024年 / 38卷 / 03期
关键词：
HER2; Esophagogastric cancer; Trastuzumab; Antibody drug conjugate; Immune modulation; Immunotherapy; Targeted therapy; ANTIBODY-DRUG CONJUGATE; GASTROESOPHAGEAL JUNCTION CANCER; GASTRIC-CANCER; TRASTUZUMAB DERUXTECAN; ADVANCED BREAST; HER2; STATUS; SINGLE-ARM; OPEN-LABEL; LAPATINIB; COMBINATION;
D O I：
10.1016/j.hoc.2024.02.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：585 / 598
页数：14
相关论文
共 50 条
  • [1] Resistance to human epidermal growth factor receptor type 2-targeted therapies
    Thery, Jean-Christophe
    Spano, Jean-Philippe
    Azria, David
    Raymond, Eric
    Llorca, Frederique Penault
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (05) : 892 - 901
  • [2] Human epidermal growth factor receptor 2-targeted therapies in breast cancer
    Nahta, Rita
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (07) : 949 - 952
  • [3] Baby steps: Pregnancy outcomes after human epidermal growth factor receptor 2-targeted therapy
    Bines, Jose
    Tevaarwerk, Amye J.
    CANCER, 2019, 125 (02) : 181 - 184
  • [4] Antitumor effect of afatinib, as a human epidermal growth factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene alterations
    Suzawa, Ken
    Toyooka, Shinichi
    Sakaguchi, Masakiyo
    Morita, Mizuki
    Yamamoto, Hiromasa
    Tomida, Shuta
    Ohtsuka, Tomoaki
    Watanabe, Mototsugu
    Hashida, Shinsuke
    Maki, Yuho
    Soh, Junichi
    Asano, Hiroaki
    Tsukuda, Kazunori
    Miyoshi, Shinichiro
    CANCER SCIENCE, 2016, 107 (01) : 45 - 52
  • [5] Response of an ERBB2-Mutated Inflammatory Breast Carcinoma to Human Epidermal Growth Factor Receptor 2-Targeted Therapy
    Ali, Siraj M.
    Alpaugh, R. Katherine
    Downing, Sean R.
    Stephens, Philip J.
    Yu, Jian Q.
    Wu, Hong
    Buell, Jamie K.
    Miller, Vincent A.
    Lipson, Doron
    Palmer, Gary A.
    Ross, Jeffrey S.
    Cristofanilli, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : E88 - E91
  • [6] Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
    Yang, ZiYan
    Wang, Wei
    Wang, Xiaojia
    Qin, ZhiQuan
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [7] Anti-epidermal growth factor receptor-targeted therapy in upper gastrointestinal tract cancers: a meta-analysis
    Li, Ailin
    Huang, Xuanzhang
    Song, Yongxi
    Chen, Xiaowan
    Sun, Jingxu
    Xu, Huimian
    Wang, Zhenning
    GROWTH FACTORS, 2015, 33 (02) : 113 - 127
  • [8] Cardiac Magnetic Resonance Imaging Findings in Human Epidermal Growth Factor Receptor 2-Targeted Therapy-Related Cardiotoxicity
    Sener, Yusuf Ziya
    Duzgun, Selin Ardali
    Hazirolan, Tuncay
    Tokgozoglu, Lale
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2023, 27 (12): : E38 - E39
  • [9] Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer
    Jiang, Ya-Kun
    Li, Wei
    Qiu, Ying-Yang
    Yue, Meng
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (06) : 2318 - 2334
  • [10] Estrogen Receptor and Receptor Tyrosine Kinase Signaling: Use of Combinatorial Hormone and Epidermal Growth Factor Receptor/Human Epidermal Growth Factor Receptor 2-Targeted Therapies for Breast Cancer
    Zabransky, Daniel J.
    Park, Ben Ho
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (10) : 1084 - 1086
12345